JPS6325783B2 - - Google Patents
Info
- Publication number
- JPS6325783B2 JPS6325783B2 JP54147162A JP14716279A JPS6325783B2 JP S6325783 B2 JPS6325783 B2 JP S6325783B2 JP 54147162 A JP54147162 A JP 54147162A JP 14716279 A JP14716279 A JP 14716279A JP S6325783 B2 JPS6325783 B2 JP S6325783B2
- Authority
- JP
- Japan
- Prior art keywords
- gel
- weight
- swollen
- manufacturing
- agarose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000499 gel Substances 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 14
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 10
- 229920000936 Agarose Polymers 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 8
- 239000012779 reinforcing material Substances 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000003999 initiator Substances 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- 238000006116 polymerization reaction Methods 0.000 claims description 4
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 239000003505 polymerization initiator Substances 0.000 claims description 2
- 239000013543 active substance Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- 239000012935 ammoniumperoxodisulfate Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000033687 granuloma formation Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Connector Housings Or Holding Contact Members (AREA)
- Pens And Brushes (AREA)
- Mechanical Coupling Of Light Guides (AREA)
Description
【発明の詳細な説明】
特開昭54−5023号公報にはとくに創傷の処置、
さらに皮膚腫瘍の後処置、アレルギーの除感作、
美容目的、露出した骨および腱、乾癬の水分保
持、ならびに細胞培養の培地として適する透明液
体包帯材料が記載され、その特徴は紙葉または帯
の形の親水性有機透明ゲルからなり、このゲルが
緩衝物質、創傷処置に常用の有効物質、栄養素ま
たは(および)発育素を含みうる水溶液で膨潤し
た状態で存在し、場合により多数の列または網状
に配置した補強材料含むことである。
この包帯材料の特殊な利点は適用がとくに簡単
であり、支障なく除去または交換することがで
き、下にある身体部分または細胞培養の目による
観察を可能にし、過剰な肉芽腫形成なしに創傷治
癒を改善し、材料を介しての有効物質添加が可能
になることである。
この透明液体包帯材料の貯蔵にはその大きい液
体含量は場合により欠点となる。さらに有効物質
の供給および分泌物のの導出に比較的時間を多く
要する。それゆえ本発明の目的は透明液体包帯材
料のすべての利点を保持しながらこれをさらに有
効物質の供給および分泌物の導出を迅速に行いう
る貯蔵容易な形で得ることである。
この目的は本発明により解決される。即ち、本
発明はアガロースまたはゼラチンおよびポリマー
のアクリル酸アミドまたはメタクリル酸アミドか
らなる、紙葉状または帯状の親水性で透明な有機
ゲルからなり、該ゲルはアガロースまたはゼラチ
ンの存在でアクリル酸アミドまたはメタクリル酸
アミドの重合によつて製造されたものである、透
明な液体包帯材料に関し、該材料が乾燥した膨潤
可能な透明シートとして存在することを特徴とす
る。
本発明の包帯材料はきわめて薄いガラスのよう
に透明シートの形で存在し、非常に大きい再膨潤
能を有し、短時間すなわち約1時間以内にその重
量の10倍以上の液体を吸収し、後に膨潤した出発
材料のすべての機械的および構造的性質を回復し
ながらほぼ完全に再乾燥する。一般に乾燥したシ
ートの重量は膨潤した含水出発材料の重量の2〜
10%、とくに3〜7%である。厚さは一般に補強
材料なしで測定して約0.5〜0.01mm、とくに0.3〜
0.003mmである。
前記公報の場合のようにゲルはポリマーのアク
リル酸アミドまたはメタクリル酸アミド10〜90重
量%およびアガロースまたはゼラチン90〜10重量
%からなつていてもよい。しかしとくに好ましい
乾燥および再構成性質は、ポリマーのアクリル酸
アミドまたはメタクリル酸アミドがアガロースま
たはゼラチンと少なくとも等重量で存在し、とく
に全ゲル乾燥物質の60〜90重量%である場合に得
られることが明らかになつた。
本発明の包帯材料の製造は前記公報の場合と同
様に行われる。すなわちモノマーまたはモノマー
混合物および少なくとも1つのゲル化可能親水性
高分子物質をゲル製造の出発物質として水性媒体
に溶解し、この溶液に紙葉または帯状材料として
望まれる厚さを与え、次に重合可能モノマーの重
合開始剤または開始剤混合物の添加によつてゲル
形成反応を開始させ、その際場合により開始剤添
加の前、間または後に補強材料を挿入し、次に膨
潤したゲルを乾燥する。
乾燥は有利に両面から均一に同時に行われる。
乾燥はその過程進行の際歪みたとえば波の発生を
避けるように行わなければならない。これは本発
明の方法の実施方式によりゲルを2つの多孔性支
持体の間で乾燥することによつて達成される。適
当な支持体はたとえば多孔性プラスチツク板、孔
明けした金属板またはシート等である。多孔性支
持体を比較的薄いシートの形で使用する場合、こ
のシート自体を再び適当な支持構造によつて支持
する。
本発明の他の実施方式によれば含水ゲルは列ま
たは網状の補強材料に張られ、この形で乾燥され
る。乾燥自体は室温またはもつと高い温度で真空
または常圧で行われる。2つの多孔性支持体の間
で乾燥する前記サンドウイツチ法を使用する場
合、1〜10mmHgの真空を使用することができ、
それによつて乾燥したシートの性質は含水出発材
料の機械的および構造的性質回復の点でほとんど
悪化しないことが確認された。真空を使用せず
に、たとえば温風で乾燥する場合、支持体として
は熱伝達を良好にするためとくに金属の板または
シートを使用する。
乾燥のためには初期厚さ0.5〜3mmのゲルがと
くに適することが明らかになつた。多孔性支持体
を使用する際の最高の結果は厚さ1〜2mmのゲル
で達成され、その際この範囲で厚さの増大ととも
に真空適用によつて真空を使用しない場合より良
好な性質が得られる。真空でなく温風で乾燥する
場合、1mm以下の厚さで最善の結果が達成され
る。
本発明により前記公報に比して著しい改善が達
成される。たとえば乾燥した包帯シートの場合包
装の困難がなくなり、滅菌保持も著しく簡単であ
る。他面すでに水分が飽和したゲルは有効物質た
とえば抗生物質、サイトスタチカ
(cytostatica)、創傷ホルモン、栄養素等を比較
的除々にしか吸収しない。というのは外部にある
液体とゲル中に含まれる液体の交換が行われなけ
ればならないからである。本発明の乾燥方式の場
合、有効物質を含む水溶液が直接吸収されるの
で、この交換は著しく促進される。
最後に乾燥形の本発明による包帯材料はあらか
じめの再膨潤なしまたは1部だけの再膨潤で分泌
の激しい創傷にとくに適する。というのは分泌物
が完全に膨潤した材料より著しく多く吸出される
からである。この方法で前記公報の包帯材料の場
合材料内の流出孔によつてのみ達成しうるのと同
量の分泌液を吸出すことができる。
次に本発明を例により説明する。
例 1〜6:
前記特開昭54−5023号公報の例2に記載された
ようにして、ゲルがポリアクリルアミド(3.5%)
およびアガロース(2%)からなる包帯材料を製
造した。このために、アクリルアミド3.5gおよ
びメチレンビスアクリルアミド91mgを蒸留水50ml
に溶解する。アガロース2gを水浴中で100℃の
蒸留水50mlに溶解し、60℃に冷却し、N,N,
N′,N′―テトラメチレンジアミン60μおよびペ
ルオクソ二硫酸アンモニウム45mgを添加した後、
アクリルアミド溶液と良く混合し、直ちに、縁の
高さ2mmの12.5×26cmの予想されたガラス板上へ
流展し、ガラス蓋で閉鎖する。30分56℃に保持
し、アクリルアミドの重合が確認されたら、以後
に該ガラス板を少なくとも24時間4℃で熟成す
る。取出した後、ゲルをリン酸塩緩衝食塩水中で
数回洗浄し、未重合物質を拡散除去する。上記組
成のほかにポリアクリルアミド(P)およびアガ
ロース(A)の含量が異なる他の5つのゲルを製造し
た。組成は次表に示す。
個々のゲルを1〜2mmの厚さにし、ポリエチレ
ンからなる多孔性プラスチツクシートの間に配置
し、2〜5mmHgの真空および室温で乾燥した。
出発材料の含水重量と得られたシートの重量の比
を%で表に示す。
再膨潤は水中へ含浸して行つた。時間および達
成された再膨潤度は同様表に示される。
【表】[Detailed Description of the Invention] JP-A No. 54-5023 particularly describes wound treatment,
In addition, post-treatment of skin tumors, desensitization of allergies,
A transparent liquid dressing material suitable for cosmetic purposes, moisture retention in exposed bones and tendons, psoriasis, and as a medium for cell culture is described, which is characterized by consisting of a hydrophilic organic transparent gel in the form of paper leaves or strips, which gel It is present in a swollen state with an aqueous solution which may contain buffering substances, active substances customary for wound treatment, nutrients or/and growth factors, and optionally contains reinforcing material arranged in a number of rows or networks. The special advantages of this dressing material are that it is particularly easy to apply, can be removed or replaced without any hindrance, allows visual observation of the underlying body part or cell culture, and allows wound healing without excessive granuloma formation. The goal is to improve this and make it possible to add active substances through the material. The storage of this transparent liquid dressing material may be disadvantageous due to its high liquid content. Moreover, the supply of active substances and the removal of secretions require relatively long periods of time. It is therefore an object of the present invention to retain all the advantages of a transparent liquid dressing material, while also obtaining it in an easy-to-storage form that allows rapid delivery of active substances and drainage of secretions. This object is solved by the present invention. That is, the present invention consists of a hydrophilic, transparent organic gel in the form of paper sheets or bands consisting of agarose or gelatin and a polymeric acrylamide or methacrylic acid amide. Transparent liquid dressing material produced by polymerization of acid amides, characterized in that the material is present as a dry, swellable transparent sheet. The dressing material of the present invention exists in the form of a very thin glass-like transparent sheet and has a very high reswelling capacity, absorbing more than 10 times its weight in liquid within a short period of time, i.e. about one hour; It is then re-dried almost completely while recovering all the mechanical and structural properties of the swollen starting material. Generally, the weight of the dry sheet is between 2 and 2 of the weight of the swollen water-containing starting material.
10%, especially 3-7%. The thickness is generally about 0.5~0.01mm measured without reinforcing material, especially 0.3~
It is 0.003mm. As in the case of said publication, the gel may consist of 10 to 90% by weight of the polymers acrylic amide or methacrylic amide and 90 to 10 % by weight of agarose or gelatin. However, particularly favorable drying and reconstitution properties may be obtained when the polymeric acrylic amide or methacrylic amide is present in at least an equal weight to the agarose or gelatin, especially between 60 and 90% by weight of the total gel dry matter. It became clear. The production of the dressing material of the present invention is carried out in the same manner as in the above-mentioned publication. That is, the monomer or monomer mixture and at least one gelatable hydrophilic polymeric substance are dissolved in an aqueous medium as starting materials for gel preparation, the solution is given the desired thickness as a sheet or strip material, and then the polymerizable The gel-forming reaction is initiated by addition of a monomer polymerization initiator or initiator mixture, optionally reinforcing material being inserted before, during or after addition of the initiator, and the swollen gel is then dried. Drying is advantageously carried out uniformly and simultaneously from both sides.
Drying must be carried out in such a way as to avoid distortions, such as the generation of waves, during the process. This is achieved by drying the gel between two porous supports according to the method of implementation of the invention. Suitable supports are, for example, porous plastic plates, perforated metal plates or sheets. If the porous support is used in the form of a relatively thin sheet, the sheet itself is again supported by a suitable support structure. According to another embodiment of the invention, the hydrogel is applied to a reinforcing material in the form of rows or networks and dried in this form. The drying itself is carried out at room temperature or at elevated temperatures under vacuum or normal pressure. When using the aforementioned sandwich method of drying between two porous supports, a vacuum of 1 to 10 mmHg can be used;
It was thereby confirmed that the properties of the dried sheet were not significantly impaired in terms of recovery of the mechanical and structural properties of the hydrous starting material. If drying is not carried out without a vacuum, for example with hot air, the support is preferably a metal plate or sheet in order to improve the heat transfer. It has been found that gels with an initial thickness of 0.5 to 3 mm are particularly suitable for drying. The best results when using porous supports are achieved with gels of 1-2 mm thickness, where in this range with increasing thickness the application of vacuum gives better properties than without vacuum. It will be done. When drying with hot air rather than vacuum, best results are achieved with a thickness of 1 mm or less. The present invention achieves a significant improvement over the above-mentioned publication. For example, dry bandage sheets eliminate packaging difficulties and are significantly easier to maintain sterile. On the other hand, gels that are already saturated with water absorb active substances, such as antibiotics, cytostatics, wound hormones, nutrients, etc., only relatively slowly. This is because an exchange of the external liquid and the liquid contained in the gel must take place. In the case of the drying method according to the invention, this exchange is significantly accelerated, since the aqueous solution containing the active substance is directly absorbed. Finally, the dressing material according to the invention in dry form is particularly suitable for highly secreting wounds without prior reswelling or with only partial reswelling. This is because secretions are sucked out significantly more than in a fully swollen material. In this way it is possible to draw out the same amount of secretion as can be achieved in the case of the dressing material of said publication only by means of drainage holes in the material. The invention will now be explained by way of example. Examples 1 to 6: The gel is made of polyacrylamide (3.5%) as described in Example 2 of JP-A-54-5023.
and agarose (2%). For this, add 3.5 g of acrylamide and 91 mg of methylenebisacrylamide to 50 ml of distilled water.
dissolve in Dissolve 2 g of agarose in 50 ml of distilled water at 100°C in a water bath, cool to 60°C,
After adding 60μ of N′,N′-tetramethylenediamine and 45mg of ammonium peroxodisulfate,
Mix well with the acrylamide solution and immediately spread onto a 12.5 x 26 cm prospective glass plate with a rim height of 2 mm and close with a glass lid. After holding at 56°C for 30 minutes and confirming the polymerization of acrylamide, the glass plate is then aged at 4°C for at least 24 hours. After removal, the gel is washed several times in phosphate buffered saline to diffuse out unpolymerized material. In addition to the above composition, five other gels with different contents of polyacrylamide (P) and agarose (A) were manufactured. The composition is shown in the table below. Individual gels were made to a thickness of 1-2 mm, placed between porous plastic sheets of polyethylene, and dried at 2-5 mm Hg vacuum and room temperature.
The table shows the ratio of the wet weight of the starting material to the weight of the sheet obtained in %. Re-swelling was carried out by immersion in water. The times and degree of reswelling achieved are also shown in the table. 【table】
Claims (1)
アクリル酸アミドまたはメタクリル酸アミドから
なる、紙葉状または帯状の親水性で透明な有機ゲ
ルからなり、該ゲルはアガロースまたはゼラチン
の存在でアクリル酸アミドまたはメタクリル酸ア
ミドの重合によつて製造されたものである、透明
な液体包帯材料において、該材料が乾燥した膨潤
可能な透明シートとして存在することを特徴とす
る透明な液体包帯材料。 2 シートが膨潤した出発材料の2〜10重量%に
乾燥している特許請求の範囲第1項記載の包帯材
料。 3 乾燥したシートの重量が膨潤した出発材料の
3〜7重量%である特許請求の範囲第2項記載の
包帯材料。 4 ゲルが重合したアクリル酸アミドまたはメタ
クリル酸アミド50〜90重量%とアガロースまたは
ゼラチン50〜10重量%からなる特許請求の範囲第
1項から第3項までのいずれか1項記載の包帯材
料。 5 列または網状に配置した補強材料を含む特許
請求の範囲第1項から第4項までのいずれか1項
記載の包帯材料。 6 アクリル酸アミドまたはメタクリル酸アミド
およびアガロースまたはゼラチンをゲル製造の出
発材料として水性媒体に溶解し、この溶液を紙葉
または帯状材料に望まれる厚さにもたらし、次に
上記の重合可能モノマーの重合開始剤または開始
剤混合物の添加によつてゲル形成反応を開始させ
る透明な液体包帯材料の製法において、膨潤した
ゲル材料を引続き乾燥することを特徴とする透明
な液体包帯材料の製法。 7 膨潤したゲルを両面から均一に乾燥する特許
請求の範囲第6項記載の製法。 8 膨潤したゲルを乾燥の間、乾燥過程進行の際
歪みを避けるように保持する特許請求の範囲第7
項記載の製法。 9 ゲルを2つの多孔性支持体の間で乾燥する特
許請求の範囲第8項記載の製法。 10 列または網状の補強材料を含むゲルを補強
材料に張つて乾燥する特許請求の範囲第8項記載
の製法。 11 厚さ0.5〜3mmの膨潤したゲルを乾燥する
特許請求の範囲第6項から第10項までのいずれ
か1項記載の製法。 12 乾燥を真空中または高温で行う特許請求の
範囲第6項から第11項までのいずれか1項記載
の製法。 13 重合開始剤添加の前、間または後に補強材
料を挿入する特許請求の範囲第6項から第12項
までのいずれか1項記載の製法。[Scope of Claims] 1. Consists of a hydrophilic and transparent organic gel in the form of paper sheets or strips consisting of agarose or gelatin and a polymeric acrylamide or methacrylic acid amide, which gel is made of acrylamide or methacrylic acid amide in the presence of agarose or gelatin. or a transparent liquid dressing material produced by the polymerization of methacrylic acid amide, characterized in that the material is present as a dry, swellable transparent sheet. 2. A dressing according to claim 1, wherein the sheet is dry to 2 to 10% by weight of the swollen starting material. 3. A dressing according to claim 2, wherein the weight of the dry sheet is from 3 to 7% by weight of the swollen starting material. 4. The dressing material according to any one of claims 1 to 3, wherein the gel comprises 50 to 90% by weight of polymerized acrylamide or methacrylic acid amide and 50 to 10% by weight of agarose or gelatin. 5. A dressing according to any one of claims 1 to 4, comprising reinforcing material arranged in rows or in a network. 6. Acrylamide or methacrylamide and agarose or gelatin are dissolved in an aqueous medium as starting materials for gel production, this solution is brought to the desired thickness in paper sheets or strips, and then the polymerization of the polymerizable monomers mentioned above is carried out. A process for producing a transparent liquid dressing material in which the gel-forming reaction is initiated by the addition of an initiator or an initiator mixture, characterized in that the swollen gel material is subsequently dried. 7. The manufacturing method according to claim 6, in which the swollen gel is dried uniformly from both sides. 8. Claim 7 for holding the swollen gel during drying to avoid distortion during the drying process.
Manufacturing method described in section. 9. The method according to claim 8, wherein the gel is dried between two porous supports. 10. The manufacturing method according to claim 8, wherein the gel containing the reinforcing material in the form of rows or networks is spread on the reinforcing material and dried. 11. The manufacturing method according to any one of claims 6 to 10, which comprises drying a swollen gel having a thickness of 0.5 to 3 mm. 12. The manufacturing method according to any one of claims 6 to 11, wherein drying is carried out in vacuum or at high temperature. 13. The method according to any one of claims 6 to 12, wherein a reinforcing material is inserted before, during or after addition of the polymerization initiator.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782849570 DE2849570A1 (en) | 1977-06-03 | 1978-11-15 | TRANSPARENT LIQUID ASSOCIATION MATERIAL |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5568369A JPS5568369A (en) | 1980-05-23 |
| JPS6325783B2 true JPS6325783B2 (en) | 1988-05-26 |
Family
ID=6054751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14716279A Granted JPS5568369A (en) | 1978-11-15 | 1979-11-15 | Transparent liquid bandage material and its preparation |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS5568369A (en) |
| AR (1) | AR223976A1 (en) |
| AT (1) | AT371723B (en) |
| AU (1) | AU525408B2 (en) |
| BE (1) | BE877580A (en) |
| CA (1) | CA1116517A (en) |
| CH (1) | CH655662B (en) |
| CS (1) | CS221904B2 (en) |
| DD (1) | DD145062A5 (en) |
| DK (1) | DK152091C (en) |
| ES (1) | ES483519A1 (en) |
| FI (1) | FI70140C (en) |
| FR (1) | FR2441390A2 (en) |
| GB (1) | GB2036042B (en) |
| HU (1) | HU180013B (en) |
| IL (1) | IL57918A (en) |
| IT (1) | IT1122228B (en) |
| NL (1) | NL7905340A (en) |
| NO (1) | NO147439C (en) |
| PL (1) | PL118053B1 (en) |
| SE (1) | SE443925B (en) |
| ZA (1) | ZA793805B (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE448203B (en) * | 1980-09-10 | 1987-02-02 | Johan Alfred Olof Johansson | FORM BODY MANUFACTURED FROM AGAR AND / OR AGAROS AND / OR A DERIVATIVE THEREOF CONTAINING PHARMACOLOGICALLY ACTIVE SUBSTANCE |
| SE446688C (en) * | 1982-09-14 | 1989-10-16 | Magnus Hoeoek | Means for the removal of microorganisms from tissues, which consist of a protein that can be bound to the microorganisms |
| JPS6045522B2 (en) * | 1982-12-08 | 1985-10-09 | 憲司 中村 | cosmetic tools |
| EP0137743A3 (en) * | 1983-09-13 | 1986-10-01 | Ed. Geistlich Söhne Ag Für Chemische Industrie | Topically administrable pharmaceutical compositions |
| AU4198785A (en) * | 1984-05-07 | 1985-11-14 | Lloyd A. Ferreira | Conductive material and biomedical electrode |
| GB8415188D0 (en) * | 1984-06-14 | 1984-07-18 | Geistlich Soehne Ag | Absorbent polymer material |
| GB8418772D0 (en) * | 1984-07-24 | 1984-08-30 | Geistlich Soehne Ag | Chemical substances |
| EP0345370A1 (en) * | 1988-06-08 | 1989-12-13 | Malliner Laboratories Inc. | Use of transparent membranes made of hydrogel polymers as a cover for various organs during surgery |
| US4587284A (en) * | 1985-06-14 | 1986-05-06 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Absorbent polymer material and its preparation |
| GB8705985D0 (en) * | 1987-03-13 | 1987-04-15 | Geistlich Soehne Ag | Dressings |
| DE3827561C1 (en) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| GB2229443A (en) * | 1989-03-07 | 1990-09-26 | American Cyanamid Co | Wound dressings |
| US5196190A (en) * | 1990-10-03 | 1993-03-23 | Zenith Technology Corporation, Limited | Synthetic skin substitutes |
| IL132880A0 (en) * | 1999-11-11 | 2001-03-19 | Hanita Lenses | Hydrogel sheets |
| FR2817479A1 (en) * | 2000-12-01 | 2002-06-07 | Philippe Maingault | CELL ACTIVATION COMPOSITION, MANUFACTURING METHOD THEREOF AND USE THEREOF FOR THE TREATMENT OF LESIONS |
| US8790688B2 (en) | 2001-12-21 | 2014-07-29 | Coloplast A/S | Wound care device for local treatment of pain in a wound |
| US20030220632A1 (en) * | 2002-05-23 | 2003-11-27 | Wolfgang Strasser | Method of using gel sheets for laser treatment |
| WO2007114726A1 (en) | 2006-04-06 | 2007-10-11 | Boris Karpovich Gavrilyuk | Monolayer wound coating and a method for the production thereof |
| DE202008009795U1 (en) | 2008-07-22 | 2008-09-25 | Neubauer, Norbert | wound dressing |
| DE202009013208U1 (en) | 2009-10-01 | 2010-02-18 | Neubauer, Norbert | vacuum valve |
| DE202009016141U1 (en) | 2009-11-26 | 2010-03-04 | Neubauer, Norbert | vacuum valve |
| DE202015007868U1 (en) | 2015-11-14 | 2016-01-26 | Norbert Neubauer | Ventilation drainage for wounds |
| CN109157673A (en) * | 2018-10-25 | 2019-01-08 | 闫玮钰 | A kind of liquid adhesive bandage |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE876311C (en) * | 1950-11-15 | 1953-05-11 | Bayer Ag | Process for the production of self-adhesive bandages |
| US3670731A (en) * | 1966-05-20 | 1972-06-20 | Johnson & Johnson | Absorbent product containing a hydrocolloidal composition |
| FR1596790A (en) * | 1968-11-27 | 1970-06-22 | ||
| ZA711727B (en) * | 1970-03-24 | 1971-12-29 | Itek Corp | Gelled burn-treating solutions |
| SE452109B (en) * | 1973-01-29 | 1987-11-16 | Pharmacia Ab | SCIENTIFIC CLEANER EXTENDED SARYTOR |
| CH616694A5 (en) * | 1974-06-27 | 1980-04-15 | Ciba Geigy Ag | Process for the preparation of crosslinked, water-insoluble, hydrophilic copolymers |
| FR2297879A1 (en) * | 1975-01-14 | 1976-08-13 | Sogeras | PROCESS FOR PREPARING REHYDRATABLE DRIED PLATES CONTAINING AGAROSE OR AGAROSE |
-
1979
- 1979-06-25 AT AT0444779A patent/AT371723B/en not_active IP Right Cessation
- 1979-06-26 NO NO792135A patent/NO147439C/en unknown
- 1979-06-27 FI FI792030A patent/FI70140C/en not_active IP Right Cessation
- 1979-06-28 AR AR277098A patent/AR223976A1/en active
- 1979-06-29 SE SE7905729A patent/SE443925B/en not_active IP Right Cessation
- 1979-07-02 DK DK278579A patent/DK152091C/en active
- 1979-07-09 BE BE0/196202A patent/BE877580A/en not_active IP Right Cessation
- 1979-07-09 NL NL7905340A patent/NL7905340A/en not_active Application Discontinuation
- 1979-07-18 HU HU79MA3181A patent/HU180013B/en unknown
- 1979-07-20 IT IT24517/79A patent/IT1122228B/en active
- 1979-07-22 IL IL57918A patent/IL57918A/en unknown
- 1979-07-23 DD DD79214548A patent/DD145062A5/en unknown
- 1979-07-24 AU AU49197/79A patent/AU525408B2/en not_active Ceased
- 1979-07-25 ZA ZA00793805A patent/ZA793805B/en unknown
- 1979-08-21 ES ES483519A patent/ES483519A1/en not_active Expired
- 1979-09-10 PL PL1979218227A patent/PL118053B1/en unknown
- 1979-11-05 GB GB7938266A patent/GB2036042B/en not_active Expired
- 1979-11-13 CA CA000339735A patent/CA1116517A/en not_active Expired
- 1979-11-14 CH CH1017479A patent/CH655662B/de unknown
- 1979-11-14 CS CS797797A patent/CS221904B2/en unknown
- 1979-11-15 FR FR7928251A patent/FR2441390A2/en active Granted
- 1979-11-15 JP JP14716279A patent/JPS5568369A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NO147439C (en) | 1983-04-13 |
| CS221904B2 (en) | 1983-04-29 |
| NO147439B (en) | 1983-01-03 |
| AU525408B2 (en) | 1982-11-04 |
| NL7905340A (en) | 1980-05-19 |
| PL218227A1 (en) | 1980-06-16 |
| IL57918A0 (en) | 1979-11-30 |
| IT1122228B (en) | 1986-04-23 |
| BE877580A (en) | 1979-11-05 |
| ES483519A1 (en) | 1980-05-16 |
| DK278579A (en) | 1980-05-16 |
| SE443925B (en) | 1986-03-17 |
| FR2441390A2 (en) | 1980-06-13 |
| FI70140C (en) | 1986-09-15 |
| CA1116517A (en) | 1982-01-19 |
| DK152091B (en) | 1988-02-01 |
| ZA793805B (en) | 1980-08-27 |
| AU4919779A (en) | 1980-05-22 |
| SE7905729L (en) | 1980-05-16 |
| FI70140B (en) | 1986-02-28 |
| FR2441390B2 (en) | 1984-10-19 |
| IT7924517A0 (en) | 1979-07-20 |
| DK152091C (en) | 1988-06-20 |
| IL57918A (en) | 1982-11-30 |
| ATA444779A (en) | 1982-12-15 |
| PL118053B1 (en) | 1981-09-30 |
| DD145062A5 (en) | 1980-11-19 |
| JPS5568369A (en) | 1980-05-23 |
| GB2036042B (en) | 1983-01-12 |
| NO792135L (en) | 1980-05-19 |
| CH655662B (en) | 1986-05-15 |
| FI792030A7 (en) | 1980-05-16 |
| AT371723B (en) | 1983-07-25 |
| HU180013B (en) | 1983-01-28 |
| GB2036042A (en) | 1980-06-25 |
| AR223976A1 (en) | 1981-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6325783B2 (en) | ||
| US4556056A (en) | Transparent fluid bandage material and the preparation and use thereof | |
| US5076265A (en) | Hydrogel sheet wound dressings | |
| CN105664238B (en) | A kind of preparation method and application of amphoteric ion aerogel dressing | |
| US4746514A (en) | Hydrogel materials formed by radiation polymerization of carbohydrates and unsaturated monomers | |
| CN103736140B (en) | A kind of medical dressing hydrogel compound fabric and its preparation method and application | |
| KR101303284B1 (en) | Hydrogel having hyaluronic acid and condroitin sulfate and manufacturing method thereof | |
| CN101693121B (en) | Method for preparing hydrogel dressing with half interpenetrating network structure and application | |
| CN108310452A (en) | A thermosensitive dextran-based hydrogel and its preparation method | |
| RU2437681C1 (en) | Wound covering with therapeutic action | |
| CN117860948A (en) | A medical composite functional antibacterial dressing and preparation method thereof | |
| CN117024775A (en) | Double dynamic cross-linked polyacrylamide/gelatin/PDA-Zn 2+ Hydrogel and preparation method and application thereof | |
| CN110038151A (en) | A kind of preparation method of bacteria cellulose-base long acting antibiotic wound dressing | |
| CN119925680A (en) | Wound repair hydrogel dressing and preparation method thereof | |
| CN110845742B (en) | Hydrogel base material, preparation method thereof and application thereof in biomedical field | |
| CN117257776A (en) | Sodium alginate hydrogel eye patch loaded with kaempferol in situ and preparation method and application thereof | |
| US3885078A (en) | Hydrogel laminates and method of manufacturing thereof | |
| CN117563039A (en) | A pH-responsive sustained-release antibacterial hemostatic gel and its preparation method and application | |
| CN117731827A (en) | Preparation method of composite bioactive inorganic silicate hydrogel wound dressing | |
| CN110898250B (en) | Self-degradable hydrogel adhesive material for skin transplantation and preparation method thereof | |
| US3825458A (en) | Method of making hydrogel laminates | |
| US20180161476A1 (en) | Hydrogel foam patch for oxygen delivery and method of manufacture | |
| CA1116519A (en) | Transparent liquid dressing material, its manufacture and use | |
| CN117717647A (en) | A kind of alginate gel dressing for women and preparation method thereof | |
| JPS6010716B2 (en) | Manufacturing method of reinforced fibrin membrane |